Fibryga Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Each bottle of FIBRYGA contains 1 g human fibrinogen. After reconstitution with 50 mL water for injections FIBRYGA contains approximately 20 mg/mL human fibrinogen.
The content of clottable protein is determined according to the European Pharmacopoeia for human fibrinogen.
Produced from the plasma of human donors.
Excipients with known effect: sodium up to 132 mg (5.8 mmol) per bottle.
Excipients/Inactive Ingredients: Powder: L-arginine hydrochloride, Glycine, Sodium chloride, Sodium citrate dihydrate.
Solvent: Water for Injections.

Manufacturer:

Octapharma

Distributor:

Pharmaniaga Marketing